Osteomalacia and Chronic Renal Failure

Overview

Journal J Clin Pathol

Specialty Pathology

Date 1981 Nov 1

PMID 7033299

Citations 6

Authors

J A Kanis

Affiliations

Soon will be listed here.

Citing Articles

Diaphyseal femoral fracture due to severe vitamin D deficiency and low parathyroid hormone levels on long-term hemodialysis: a case report.

Hatano M, Kitajima I, Isawa K, Hirota Y, Suwabe T, Hoshino J Arch Osteoporos. 2020; 15(1):179.

PMID: 33180218 PMC: 7661412. DOI: 10.1007/s11657-020-00849-7.

Environmental effects of aluminium.

Rosseland B, Eldhuset T, Staurnes M Environ Geochem Health. 2013; 12(1-2):17-27.

PMID: 24202562 DOI: 10.1007/BF01734045.

Bone histoquantitative findings and histochemical staining reactions for aluminium in chronic renal failure patients treated with haemodialysis fluids containing high and low concentrations of aluminium.

McClure J, Fazzalari N, Fassett R, Pugsley D J Clin Pathol. 1983; 36(11):1281-7.

PMID: 6630577 PMC: 498546. DOI: 10.1136/jcp.36.11.1281.

Safety of treatment for subclinical osteomalacia in the elderly.

Hosking D, Campbell G, Kemm J, Cotton R, Boyd R Br Med J (Clin Res Ed). 1984; 289(6448):785-7.

PMID: 6434081 PMC: 1442959. DOI: 10.1136/bmj.289.6448.785.

Vitamin D metabolites and analogues, diphosphonates, danazol, and bromocriptine.

Paterson C, Feely J Br Med J (Clin Res Ed). 1983; 286(6378):1625-8.

PMID: 6405917 PMC: 1547935. DOI: 10.1136/bmj.286.6378.1625.

References

Christiansen C, RODBRO P, Christensen M, Hartnack B, TRANSBOL I . Deterioration of renal function during treatment of chronic renal failure with 1,25-dihydroxycholecalciferol. Lancet. 1978; 2(8092 Pt 1):700-3. DOI: 10.1016/s0140-6736(78)92702-2. View

Naik R, Cundy T, Robinson B, Russell R, Kanis J . Effects of vitamin D metabolites and analogues on renal function. Nephron. 1981; 28(1):17-25. DOI: 10.1159/000182088. View

Meyrier A, Marsac J, RICHET G . The influence of a high calcium carbonate intake on bone disease in patients undergoing hemodialysis. Kidney Int. 1973; 4(2):146-53. DOI: 10.1038/ki.1973.93. View

Woods C, MORGAN D, Paterson C, Gossmann H . Measurement of osteoid in bone biopsy. J Pathol Bacteriol. 1968; 95(2):441-7. DOI: 10.1002/path.1700950214. View

Weisman Y, EISENBERG Z, LEIB L, HARELL A, Shasha S, Edelstein S . Serum concentrations of 24,25-dihydroxy vitamin D in different degrees of chronic renal failure. Br Med J. 1980; 281(6242):712-3. PMC: 1713984. DOI: 10.1136/bmj.281.6242.712. View

Chesney R, Moorthy A, Eisman J, Jax D, Mazess R, DeLuca H . Increased growth after long-term oral 1alpha,25-vitamin D3 in childhood renal osteodystrophy. N Engl J Med. 1978; 298(5):238-42. DOI: 10.1056/NEJM197802022980503. View

Ritz E, Krempien B, Mehls O, MALLUCHE H . Skeletal abnormalities in chronic renal insufficiency before and during maintenance hemodialysis. Kidney Int. 1973; 4(2):116-27. DOI: 10.1038/ki.1973.90. View

De Luca H . Recent advances in our understanding of the vitamin D endocrine system. J Lab Clin Med. 1976; 87(1):7-26. View

Kanis J, HENDERSON R, Heynen G, LEDINGHAM J, Russell R, Smith R . Renal osteodystrophy in nondialysed adolescents. Long-term treatment with 1alpha-hydroxycholecalciferol. Arch Dis Child. 1977; 52(6):473-81. PMC: 1544715. DOI: 10.1136/adc.52.6.473. View

10.

YENDT E, Connor T, Howard J . In vitro calcification of rachitic rat cartilage in normal and pathological human sera with some observations on the pathogenesis of renal rickets. Bull Johns Hopkins Hosp. 1955; 96(1):1-19. View

11.

Kanis J, Russell R . Rate of reversal of hypercalcaemia and hypercalciuria induced by vitamin D and its 1alpha-hydroxylated derivatives. Br Med J. 1977; 1(6053):78-81. PMC: 1604081. DOI: 10.1136/bmj.1.6053.78. View

12.

Haussler M, McCain T . Basic and clinical concepts related to vitamin D metabolism and action (first of two parts). N Engl J Med. 1977; 297(18):974-83. DOI: 10.1056/NEJM197711032971804. View

13.

Frost H . Relation between bone tissue and cell population dynamics, histology and tetracycline labeling. Clin Orthop Relat Res. 1966; 49:65-75. View

14.

Kanis J, Russell R, Taylor C, Cundy T, Andrade A, Heynen G . The relationship between disturbed metabolism of vitamin D and bone disease in chronic renal failure. Proc Eur Dial Transplant Assoc. 1979; 16:630-6. View

15.

Moorhead J, Wills M, Ahmed K, Baillod R, Varghese Z, Tatler G . Hypophosphataemic osteomalacia after cadaveric renal transplantation. Lancet. 1974; 1(7860):694-7. DOI: 10.1016/s0140-6736(74)92902-x. View

16.

Jenkins M, Harris M, Wills M . The effect of phenytoin on parathyroid extract and 25-hydroxycholecalciferol-induced bone resorption: adenosine 3, 5 cyclic monophosphate production. Calcif Tissue Res. 1974; 16(2):163-7. DOI: 10.1007/BF02008223. View

17.

STANBURY S, LUMB G . Metabolic studies of renal osteodystrophy. I. Calcium, phosphorus and nitrogen metabolism in rickets, osteomalacia and hyperparathyroidism complicating chronic uremia and in the osteomalacia of the adult Fanconi syndrome. Medicine (Baltimore). 1962; 41:1-34. View

18.

LEMANN Jr J, Litzow J, Lennon E . The effects of chronic acid loads in normal man: further evidence for the participation of bone mineral in the defense against chronic metabolic acidosis. J Clin Invest. 1966; 45(10):1608-14. PMC: 292842. DOI: 10.1172/JCI105467. View

19.

Kanis J, Cundy T, Earnshaw M, HENDERSON R, Heynen G, Naik R . Treatment of renal bone disease with 1 alpha-hydroxylated derivatives of vitamin D3. Clinical, biochemical, radiographic and histological responses. Q J Med. 1979; 48(190):289-322. View

20.

Flendrig J, Kruis H, Das H . Letter: Aluminum and dialysis dementia. Lancet. 1976; 1(7971):1235. DOI: 10.1016/s0140-6736(76)92177-2. View